{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:49:25Z","timestamp":1792784965801,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100001062","name":"Wallace H. Coulter Foundation","doi-asserted-by":"publisher","award":["Coulter-Drexel Translational Research Partnership"],"award-info":[{"award-number":["Coulter-Drexel Translational Research Partnership"]}],"id":[{"id":"10.13039\/100001062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008211","name":"Drexel University","doi-asserted-by":"publisher","award":["Startup fund"],"award-info":[{"award-number":["Startup fund"]}],"id":[{"id":"10.13039\/100008211","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Margaret Q. Landenberger Research Foundation","id":[{"id":"https:\/\/ror.org\/014077m09","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["1U54CA244438"],"award-info":[{"award-number":["1U54CA244438"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76570-9","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:34:37Z","timestamp":1788788077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Programmable CAR-engaging particles rewire human CAR T-cell signaling for sustainable ex vivo expansion"],"prefix":"10.1038","volume":"17","author":[{"given":"Qinghe","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon","family":"Flemming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2518-5626","authenticated-orcid":false,"given":"Yuanzhou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5119-9791","authenticated-orcid":false,"given":"Heinz","family":"Hammerlindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0032-8140","authenticated-orcid":false,"given":"Greg M.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3755-0669","authenticated-orcid":false,"given":"Ricardo","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1578-2247","authenticated-orcid":false,"given":"Jasper Z.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3968-4908","authenticated-orcid":false,"given":"Rogelio A.","family":"Hern\u00e1ndez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ania-Ariadna","family":"Baetica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7900-8993","authenticated-orcid":false,"given":"Joseph A.","family":"Fraietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8262-1190","authenticated-orcid":false,"given":"Justin","family":"Eyquem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6560-3783","authenticated-orcid":false,"given":"Chun J.","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4052-8056","authenticated-orcid":false,"given":"Wendell A.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7313-3574","authenticated-orcid":false,"given":"Qizhi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3409-9208","authenticated-orcid":false,"given":"Tejal A.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7733-9094","authenticated-orcid":false,"given":"Xiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"76570_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41571-023-00754-1","volume":"20","author":"KM Cappell","year":"2023","unstructured":"Cappell, K. M. & Kochenderfer, J. N. Long-term outcomes following CAR T cell therapy: what we know so far. Nat. Rev. Clin. Oncol. 20, 359\u2013371 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"76570_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.omto.2023.04.003","volume":"29","author":"L Shiqi","year":"2023","unstructured":"Shiqi, L. et al. Durable remission related to CAR-T persistence in R\/R B-ALL and long-term persistence potential of prime CAR-T. Mol. Ther. Oncolytics 29, 107\u2013117 (2023).","journal-title":"Mol. Ther. Oncolytics"},{"key":"76570_CR3","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1056\/NEJMoa2024850","volume":"384","author":"NC Munshi","year":"2021","unstructured":"Munshi, N. C. et al. Idecabtagene vicleucel in relapsed and refractory multiple myeloma. N. Engl. J. Med. 384, 705\u2013716 (2021).","journal-title":"N. Engl. J. Med."},{"key":"76570_CR4","doi-asserted-by":"publisher","first-page":"103941","DOI":"10.1016\/j.ebiom.2022.103941","volume":"77","author":"D Gumber","year":"2022","unstructured":"Gumber, D. & Wang, L. D. Improving CAR-T immunotherapy: overcoming the challenges of T cell exhaustion. EBioMedicine 77, 103941 (2022).","journal-title":"EBioMedicine"},{"key":"76570_CR5","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1158\/2326-6066.CIR-17-0405","volume":"6","author":"S Ghassemi","year":"2018","unstructured":"Ghassemi, S. et al. Reducing ex vivo culture improves the antileukemic activity of chimeric antigen receptor (CAR) T cells. Cancer Immunol. Res. 6, 1100\u20131109 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"76570_CR6","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/j.xphs.2020.12.015","volume":"110","author":"J Jiang","year":"2021","unstructured":"Jiang, J. & Ahuja, S. Addressing patient to patient variability for autologous CAR T therapies. J. Pharm. Sci. 110, 1871\u20131876 (2021).","journal-title":"J. Pharm. Sci."},{"key":"76570_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41551-021-00842-6","volume":"6","author":"S Ghassemi","year":"2022","unstructured":"Ghassemi, S. et al. Rapid manufacturing of non-activated potent CAR T cells. Nat. Biomed. Eng. 6, 118\u2013128 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"76570_CR8","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/s41587-023-01687-x","volume":"41","author":"DC Kirouac","year":"2023","unstructured":"Kirouac, D. C. et al. Deconvolution of clinical variance in CAR-T cell pharmacology and response. Nat. Biotechnol. 41, 1606\u20131617 (2023).","journal-title":"Nat. Biotechnol."},{"key":"76570_CR9","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41586-022-05626-9","volume":"614","author":"AG Soerens","year":"2023","unstructured":"Soerens, A. G. et al. Functional T cells are capable of supernumerary cell division and longevity. Nature 614, 762\u2013766 (2023).","journal-title":"Nature"},{"key":"76570_CR10","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.4049\/jimmunol.159.12.5921","volume":"159","author":"BL Levine","year":"1997","unstructured":"Levine, B. L. et al. Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J. Immunol. 159, 5921\u20135930 (1997).","journal-title":"J. Immunol."},{"key":"76570_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nbt0202-143","volume":"20","author":"MV Maus","year":"2002","unstructured":"Maus, M. V. et al. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB. Nat. Biotechnol. 20, 143\u2013148 (2002).","journal-title":"Nat. Biotechnol."},{"key":"76570_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1006\/clim.2002.5277","volume":"105","author":"AK Thomas","year":"2002","unstructured":"Thomas, A. K., Maus, M. V., Shalaby, W. S., June, C. H. & Riley, J. L. A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes. Clin. Immunol. 105, 259\u2013272 (2002).","journal-title":"Clin. Immunol."},{"key":"76570_CR13","doi-asserted-by":"publisher","first-page":"e20232368","DOI":"10.1084\/jem.20232368","volume":"221","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Induction of immortal-like and functional CAR T cells by defined factors. J. Exp. Med. 221, e20232368 (2024).","journal-title":"J. Exp. Med."},{"key":"76570_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-024-07300-8","volume":"629","author":"AE Doan","year":"2024","unstructured":"Doan, A. E. et al. FOXO1 is a master regulator of memory programming in CAR T cells. Nature 629, 211\u2013218 (2024).","journal-title":"Nature"},{"key":"76570_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41586-024-07242-1","volume":"629","author":"JD Chan","year":"2024","unstructured":"Chan, J. D. et al. FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy. Nature 629, 201\u2013210 (2024).","journal-title":"Nature"},{"key":"76570_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41586-018-0178-z","volume":"558","author":"JA Fraietta","year":"2018","unstructured":"Fraietta, J. A. et al. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature 558, 307\u2013312 (2018).","journal-title":"Nature"},{"key":"76570_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-019-1805-z","volume":"576","author":"RC Lynn","year":"2019","unstructured":"Lynn, R. C. et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature 576, 293\u2013300 (2019).","journal-title":"Nature"},{"key":"76570_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1158\/2643-3230.BCD-23-0272","volume":"5","author":"M Abou-El-Enein","year":"2024","unstructured":"Abou-El-Enein, M. The fate(s) of CAR T-cell therapy: navigating the risks of CAR+ T-cell malignancy. Blood Cancer Discov. 5, 249\u2013257 (2024).","journal-title":"Blood Cancer Discov."},{"key":"76570_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1006\/excr.1996.0299","volume":"228","author":"AG Bodnar","year":"1996","unstructured":"Bodnar, A. G., Kim, N. W., Effros, R. B. & Chiu, C. P. Mechanism of telomerase induction during T cell activation. Exp. Cell Res. 228, 58\u201364 (1996).","journal-title":"Exp. Cell Res."},{"key":"76570_CR20","doi-asserted-by":"publisher","first-page":"6689","DOI":"10.4049\/jimmunol.178.11.6689","volume":"178","author":"AN Akbar","year":"2007","unstructured":"Akbar, A. N. & Vukmanovic-Stejic, M. Telomerase in T lymphocytes: use it and lose it? J. Immunol. 178, 6689\u20136694 (2007).","journal-title":"J. Immunol."},{"key":"76570_CR21","doi-asserted-by":"publisher","first-page":"103989","DOI":"10.1016\/j.cellimm.2019.103989","volume":"345","author":"M Patrick","year":"2019","unstructured":"Patrick, M. & Weng, N. P. Expression and regulation of telomerase in human T cell differentiation, activation, aging and diseases. Cell Immunol. 345, 103989 (2019).","journal-title":"Cell Immunol."},{"key":"76570_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41423-022-00949-z","volume":"20","author":"M Jin","year":"2023","unstructured":"Jin, M. & Huang, J. D. New mechanism to promote long-term T-cell immunity by telomere transfer from antigen-presenting cells. Cell Mol. Immunol. 20, 117\u2013118 (2023).","journal-title":"Cell Mol. Immunol."},{"key":"76570_CR23","doi-asserted-by":"publisher","first-page":"1100535","DOI":"10.3389\/fimmu.2023.1100535","volume":"14","author":"L Roger","year":"2023","unstructured":"Roger, L. et al. T cell memory revisited using single telomere length analysis. Front Immunol. 14, 1100535 (2023).","journal-title":"Front Immunol."},{"key":"76570_CR24","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","volume":"56","author":"JR Giles","year":"2023","unstructured":"Giles, J. R., Globig, A. M., Kaech, S. M. & Wherry, E. J. CD8(+) T. cells in the cancer-immunity cycle. Immunity 56, 2231\u20132253 (2023).","journal-title":"Immunity"},{"key":"76570_CR25","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.1016\/j.cell.2021.11.016","volume":"184","author":"CR Good","year":"2021","unstructured":"Good, C. R. et al. An NK-like CAR T cell transition in CAR T cell dysfunction. Cell 184, 6081\u20136100 (2021).","journal-title":"Cell"},{"key":"76570_CR26","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2021.06.012","volume":"39","author":"GM Delgoffe","year":"2021","unstructured":"Delgoffe, G. M. et al. The role of exhaustion in CAR T cell therapy. Cancer Cell 39, 885\u2013888 (2021).","journal-title":"Cancer Cell"},{"key":"76570_CR27","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41565-020-00813-z","volume":"16","author":"X Huang","year":"2021","unstructured":"Huang, X. et al. DNA scaffolds enable efficient and tunable functionalization of biomaterials for immune cell modulation. Nat. Nanotechnol. 16, 214\u2013223 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"76570_CR28","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1038\/s41596-023-00887-8","volume":"18","author":"P Hadley","year":"2023","unstructured":"Hadley, P. et al. Precise surface functionalization of PLGA particles for human T cell modulation. Nat. Protoc. 18, 3289\u20133321 (2023).","journal-title":"Nat. Protoc."},{"key":"76570_CR29","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.immuni.2016.04.020","volume":"44","author":"JH Esensten","year":"2016","unstructured":"Esensten, J. H., Helou, Y. A., Chopra, G., Weiss, A. & Bluestone, J. A. CD28 costimulation: from mechanism to therapy. Immunity 44, 973\u2013988 (2016).","journal-title":"Immunity"},{"key":"76570_CR30","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1084\/jem.188.4.619","volume":"188","author":"A Krause","year":"1998","unstructured":"Krause, A. et al. Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes. J. Exp. Med. 188, 619\u2013626 (1998).","journal-title":"J. Exp. Med."},{"key":"76570_CR31","doi-asserted-by":"publisher","first-page":"eabm1463","DOI":"10.1126\/scitranslmed.abm1463","volume":"14","author":"DB Goodman","year":"2022","unstructured":"Goodman, D. B. et al. Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies. Sci. Transl. Med 14, eabm1463 (2022).","journal-title":"Sci. Transl. Med"},{"key":"76570_CR32","first-page":"101399","volume":"33","author":"KC Bui","year":"2023","unstructured":"Bui, K. C. et al. X-ray-irradiated K562 feeder cells for expansion of functional CAR-T cells. Biochem. Biophys. Rep. 33, 101399 (2023).","journal-title":"Biochem. Biophys. Rep."},{"key":"76570_CR33","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.3324\/haematol.2024.285101","volume":"109","author":"C Georgiadis","year":"2024","unstructured":"Georgiadis, C. et al. Umbilical cord blood T cells can be isolated and enriched by CD62L selection for use in \u2018off the shelf\u2019 chimeric antigen receptor T-cell therapies to widen transplant options. Haematologica 109, 3941\u20133951 (2024).","journal-title":"Haematologica"},{"key":"76570_CR34","doi-asserted-by":"publisher","first-page":"101250","DOI":"10.1016\/j.omtm.2024.101250","volume":"32","author":"J Dias","year":"2024","unstructured":"Dias, J., Garcia, J., Agliardi, G. & Roddie, C. CAR-T cell manufacturing landscape-Lessons from the past decade and considerations for early clinical development. Mol. Ther. Methods Clin. Dev. 32, 101250 (2024).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"76570_CR35","doi-asserted-by":"publisher","first-page":"e20230903","DOI":"10.1084\/jem.20230903","volume":"221","author":"M Ayala Ceja","year":"2024","unstructured":"Ayala Ceja, M., Khericha, M., Harris, C. M., Puig-Saus, C. & Chen, Y. Y. CAR-T cell manufacturing: major process parameters and next-generation strategies. J. Exp. Med 221, e20230903 (2024).","journal-title":"J. Exp. Med"},{"key":"76570_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.omtm.2021.12.005","volume":"24","author":"JJ Joedicke","year":"2022","unstructured":"Joedicke, J. J. et al. Accelerating clinical-scale production of BCMA CAR T cells with defined maturation stages. Mol. Ther. Methods Clin. Dev. 24, 181\u2013198 (2022).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"76570_CR37","doi-asserted-by":"publisher","first-page":"e150807","DOI":"10.1172\/JCI150807","volume":"132","author":"S Arcangeli","year":"2022","unstructured":"Arcangeli, S. et al. CAR T cell manufacturing from naive\/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome. J. Clin. Investig. 132, e150807 (2022).","journal-title":"J. Clin. Investig."},{"key":"76570_CR38","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3389\/fimmu.2020.01217","volume":"11","author":"S Arcangeli","year":"2020","unstructured":"Arcangeli, S. et al. Next-generation manufacturing protocols enriching T(SCM) caR T cells can overcome disease-specific T cell defects in cancer patients. Front. Immunol. 11, 1217 (2020).","journal-title":"Front. Immunol."},{"key":"76570_CR39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","volume":"6","author":"K Shah","year":"2021","unstructured":"Shah, K., Al-Haidari, A., Sun, J. & Kazi, J. U. T cell receptor (TCR) signaling in health and disease. Signal Transduct. Target Ther. 6, 412 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"76570_CR40","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/30.10.e47","volume":"30","author":"RM Cawthon","year":"2002","unstructured":"Cawthon, R. M. Telomere measurement by quantitative PCR. Nucleic Acids Res. 30, e47 (2002).","journal-title":"Nucleic Acids Res."},{"key":"76570_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/bs.mcb.2022.12.009","volume":"181","author":"G Saretzki","year":"2024","unstructured":"Saretzki, G. Measuring telomerase activity using TRAP assays. Methods Cell Biol. 181, 127\u2013149 (2024).","journal-title":"Methods Cell Biol."},{"key":"76570_CR42","doi-asserted-by":"publisher","first-page":"e148546","DOI":"10.1172\/JCI148546","volume":"132","author":"M Corrado","year":"2022","unstructured":"Corrado, M. & Pearce, E. L. Targeting memory T cell metabolism to improve immunity. J. Clin. Invest 132, e148546 (2022).","journal-title":"J. Clin. Invest"},{"key":"76570_CR43","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2016.01.021","volume":"44","author":"OU Kawalekar","year":"2016","unstructured":"Kawalekar, O. U. et al. Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells. Immunity 44, 380\u2013390 (2016).","journal-title":"Immunity"},{"key":"76570_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48704-4","volume":"15","author":"R Setoguchi","year":"2024","unstructured":"Setoguchi, R. et al. Memory CD8 T cells are vulnerable to chronic IFN-gamma signals but not to CD4 T cell deficiency in MHCII-deficient mice. Nat. Commun. 15, 4418 (2024).","journal-title":"Nat. Commun."},{"key":"76570_CR45","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.4049\/jimmunol.0902708","volume":"184","author":"O Sercan","year":"2010","unstructured":"Sercan, O., Stoycheva, D., Hammerling, G. J., Arnold, B. & Schuler, T. IFN-gamma receptor signaling regulates memory CD8+ T cell differentiation. J. Immunol. 184, 2855\u20132862 (2010).","journal-title":"J. Immunol."},{"key":"76570_CR46","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.4049\/jimmunol.179.4.2115","volume":"179","author":"K Tewari","year":"2007","unstructured":"Tewari, K., Nakayama, Y. & Suresh, M. Role of direct effects of IFN-gamma on T cells in the regulation of CD8 T cell homeostasis. J. Immunol. 179, 2115\u20132125 (2007).","journal-title":"J. Immunol."},{"key":"76570_CR47","doi-asserted-by":"publisher","first-page":"7080","DOI":"10.18632\/oncotarget.27389","volume":"10","author":"AC Ravanpay","year":"2019","unstructured":"Ravanpay, A. C. et al. EGFR806-CAR T cells selectively target a tumor-restricted EGFR epitope in glioblastoma. Oncotarget 10, 7080\u20137095 (2019).","journal-title":"Oncotarget"},{"key":"76570_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0238-6","volume":"9","author":"H Li","year":"2018","unstructured":"Li, H. et al. Antitumor activity of EGFR-specific CAR T cells against non-small-cell lung cancer cells in vitro and in mice. Cell Death Dis. 9, 177 (2018).","journal-title":"Cell Death Dis."},{"key":"76570_CR49","doi-asserted-by":"publisher","first-page":"eade3369","DOI":"10.1126\/sciimmunol.ade3369","volume":"8","author":"JE Wu","year":"2023","unstructured":"Wu, J. E. et al. In vitro modeling of CD8(+) T cell exhaustion enables CRISPR screening to reveal a role for BHLHE40. Sci. Immunol. 8, eade3369 (2023).","journal-title":"Sci. Immunol."},{"key":"76570_CR50","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/nm.2446","volume":"17","author":"L Gattinoni","year":"2011","unstructured":"Gattinoni, L. et al. A human memory T cell subset with stem cell-like properties. Nat. Med. 17, 1290\u20131297 (2011).","journal-title":"Nat. Med."},{"key":"76570_CR51","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1016\/j.immuni.2023.11.005","volume":"56","author":"JC Beltra","year":"2023","unstructured":"Beltra, J. C. et al. Stat5 opposes the transcription factor Tox and rewires exhausted CD8(+) T cells toward durable effector-like states during chronic antigen exposure. Immunity 56, 2699\u20132718 e2611 (2023).","journal-title":"Immunity"},{"key":"76570_CR52","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/s41590-020-0791-5","volume":"21","author":"G Galletti","year":"2020","unstructured":"Galletti, G. et al. Two subsets of stem-like CD8(+) memory T cell progenitors with distinct fate commitments in humans. Nat. Immunol. 21, 1552\u20131562 (2020).","journal-title":"Nat. Immunol."},{"key":"76570_CR53","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","volume":"24","author":"JA Fraietta","year":"2018","unstructured":"Fraietta, J. A. et al. Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat. Med 24, 563\u2013571 (2018).","journal-title":"Nat. Med"},{"key":"76570_CR54","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41565-023-01584-z","volume":"19","author":"F Du","year":"2024","unstructured":"Du, F. et al. Controlled adsorption of multiple bioactive proteins enables targeted mast cell nanotherapy. Nat. Nanotechnol. 19, 698\u2013704 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"76570_CR55","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1021\/acscentsci.2c00227","volume":"8","author":"Z Huang","year":"2022","unstructured":"Huang, Z. et al. Rational vaccinology: harnessing nanoscale chemical design for cancer immunotherapy. ACS Cent. Sci. 8, 692\u2013704 (2022).","journal-title":"ACS Cent. Sci."},{"key":"76570_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35948-9","volume":"14","author":"JM Mazet","year":"2023","unstructured":"Mazet, J. M. et al. IFNgamma signaling in cytotoxic T cells restricts anti-tumor responses by inhibiting the maintenance and diversity of intra-tumoral stem-like T cells. Nat. Commun. 14, 321 (2023).","journal-title":"Nat. Commun."},{"key":"76570_CR57","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41591-022-02182-7","volume":"29","author":"S Mailankody","year":"2023","unstructured":"Mailankody, S. et al. Allogeneic BCMA-targeting CAR T cells in relapsed\/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results. Nat. Med 29, 422\u2013429 (2023).","journal-title":"Nat. Med"},{"key":"76570_CR58","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1016\/j.cell.2024.07.056","volume":"187","author":"DJ Baker","year":"2024","unstructured":"Baker, D. J. & June, C. H. Off-the-shelf CAR-T cells could prove paradigm shifting for autoimmune diseases. Cell 187, 4826\u20134828 (2024).","journal-title":"Cell"},{"key":"76570_CR59","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41586-024-07762-w","volume":"634","author":"Z Bai","year":"2024","unstructured":"Bai, Z. et al. Single-cell CAR T atlas reveals type 2 function in 8-year leukemia remission. Nature 634, 702\u2013711 (2024).","journal-title":"Nature"},{"key":"76570_CR60","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","volume":"602","author":"JJ Melenhorst","year":"2022","unstructured":"Melenhorst, J. J. et al. Decade-long leukemia remissions with persistence of CD4(+) CAR T cells. Nature 602, 503\u2013509 (2022).","journal-title":"Nature"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76570-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76570-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76570-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:32:22Z","timestamp":1791412342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76570-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76570"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76570-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"X.H., T.A.D., Q.T., W.A.L., and J.Z.W. are inventors of pending patents related to the technology described in the manuscript. Q.Z., L.F., Y.C., T.M., H.H., G.A., R.A., J.Z.W., R.H., S.M., J.A.F., J.E., and C.J.Y. declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10581"}}